How to Separate IgG from Host Cell Proteins

150 kDa antibody (pI 8.5) vs. diverse HCP mixture (pI 4–6) — Protein A affinity gives >95% purity in one step

Property Comparison

IgG Antibody (Target)

Molecular Weight150,000 Da
TypeMonoclonal Antibody
Isoelectric Point8.0–9.0
Fc RegionBinds Protein A
Typical Titer1–10 g/L
Hydrodynamic Radius~5.3 nm
Structure2 heavy + 2 light chains
vs

Host Cell Proteins (Impurity)

Molecular Weight10–200 kDa (mixture)
TypeCHO cell lysate proteins
Isoelectric Point4–6 (mostly acidic)
Fc RegionNone
Typical Level100,000–500,000 ppm
Diversity~3,000 unique proteins
ConcernImmunogenic, must be <100 ppm

Why This Separation Works

Protein A is a bacterial surface protein that specifically binds the Fc region of IgG antibodies with nanomolar affinity. No HCP has this binding motif:

ComponentProtein A BindingKdGoes To
IgG AntibodyStrong (Fc-mediated)~10 nMEluate (product)
Host Cell ProteinsNone/negligibleFlow-through (waste)

This is the gold standard for mAb purification. One Protein A step typically reduces HCP from >100,000 ppm to <1,000 ppm—a 100-fold purification factor.

Recommended Process Route

1

Harvest Clarification

Remove CHO cells and debris by centrifugation (3,000–5,000 ×g) followed by depth filtration (0.2–0.5 μm). Final 0.2 μm bioburden reduction filter. Target: <5 NTU turbidity.

Clarification
2

Protein A Affinity Chromatography

Load clarified harvest at pH 7.0–7.4 onto Protein A resin (MabSelect SuRe, capacity 30–50 g/L). Wash with high-salt buffer (0.5 M NaCl) to remove non-specific binders. Elute at pH 3.0–3.5 with citrate buffer. Dynamic binding capacity: 35–50 g IgG per L resin.

Key separation step
3

Low pH Viral Inactivation

Hold Protein A eluate at pH 3.5 for 30–60 min to inactivate enveloped viruses (regulatory requirement). Neutralize to pH 5.0–5.5 for next step. Filter any precipitates with 0.2 μm filter.

Viral safety
4

Cation Exchange Polishing (Bind–Elute)

Load at pH 5.0 onto SP Sepharose or similar CEX resin. IgG (pI ~8.5) is positively charged and binds. Elute with NaCl gradient (0–300 mM). Removes aggregates, leached Protein A ligand, and residual HCP.

Aggregate removal
5

Anion Exchange Flow-Through

Pass through Q Sepharose or AEX membrane adsorber at pH 7–8. IgG (pI 8.5, net positive) flows through unretained. DNA (<10 pg/dose), endotoxin, and acidic HCP bind and are removed. Final HCP: <100 ppm.

DNA & endotoxin clearance

Expected Results

85–95%
Overall IgG Yield
>99%
IgG Purity
5 steps
Total Process Length

Final HCP <100 ppm, DNA <10 pg/dose, aggregates <1%, leached Protein A <5 ng/mL. Meets ICH and FDA guidelines for therapeutic antibodies.

Alternative Techniques

TechniqueFeasibilityNotes
Cation Exchange (Capture)ModerateIgG binds at pH 5 (pI 8.5). Can replace Protein A for cost savings, but lower selectivity (~80% purity vs >95%). Requires more polishing.
Hydrophobic Interaction (HIC)ModerateGood polishing step. Bind at high salt (1–2 M ammonium sulfate), elute with decreasing salt. Removes aggregates effectively.
Mixed-Mode ChromatographyGoodCapto Adhere, MEP HyperCel. Combines ion exchange and hydrophobic interactions. Emerging alternative to AEX polishing.
Protein G AffinityGoodBroader IgG subclass binding than Protein A. Useful for IgG3 which has weak Protein A affinity. Higher cost.

Frequently Asked Questions

Why is Protein A chromatography so expensive?

Protein A resin costs $8,000–15,000 per liter, making it the most expensive step in mAb manufacturing. However, modern resins withstand 200+ cycles with NaOH CIP, amortizing cost to $20–50 per gram antibody. The single-step >95% purity justifies the cost for therapeutics.

Can I skip the polishing steps?

For research-grade antibody, Protein A alone may suffice (>95% purity). For therapeutic mAbs, FDA requires demonstration of HCP <100 ppm, DNA <10 pg/dose, and viral clearance (4+ log). Polishing steps are essential for regulatory compliance.

What about non-antibody Fc-fusion proteins?

Fc-fusion proteins (e.g., etanercept, abatacept) also bind Protein A via their Fc domain. The same platform process applies, though binding capacity and elution pH may differ slightly due to the fusion partner.

Simulate This Process Yourself

Build this mAb purification platform process in untangle.bio with drag-and-drop, then optimize yield, purity, and cost.

Open untangle.bio